Blue Review
A Provider Publication
print page

November 2022

Prior Authorization Codes Updated for Commercial Members, Effective January 1

What’s Changing: Blue Cross and Blue Shield of Oklahoma (BCBSOK) is changing prior authorization requirements that may apply to some commercial members to reflect new, replaced or removed codes. These changes are based on updates from Utilization Management prior authorization assessment, Current Procedural Terminology (CPT®) code changes released by the American Medical Association or Healthcare Common Procedure Coding System (HCPCS) changes from the Centers for Medicaid & Medicare Services. A summary of changes is included below.

Important Reminder: Always check eligibility and benefits first through the Availity® Provider Portal or your preferred vendor portal, prior to rendering services. This step will confirm prior authorization requirements and utilization management vendors, if applicable.
Changes are:

  • Jan. 1, 2023 – Removal of Musculoskeletal – Joint and Spine codes previously reviewed by AIM Specialty Health® (AIM)
  • Jan. 1, 2023 – Removal of a Molecular Genetic Lab code previously reviewed by AIM
  • Jan. 1, 2023 – Removal of a Specialty Pharmacy code previously reviewed by BCBSOK, that will continue to be reviewed by AIM
  • Jan. 1, 2023 – Replacement of a Specialty Pharmacy code reviewed by AIM
  • Jan. 1, 2023 – Removal of Orthopedic Musculoskeletal codes previously reviewed by BCBSOK

Training Reminder:
Contact your Network Representative for additional training on using the AIM Specialty Health ProviderPortal.

More Information: For a revised list of codes, go to our provider website in the preauthorization section.